Stay updated on Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4 on the page, indicating an internal system update. No study details, eligibility criteria, or visible content were changed.
    Difference
    0.1%
    Check dated 2026-07-27T05:54:43.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Update timestamps on the study record were revised, adding newer dates (2026-07-15, 2026-07-13, 2026-07) and removing older ones (2026-07-07, 2026-06-16, 2026-06). This reflects updated tracking of when the study record was last changed.
    Difference
    0.2%
    Check dated 2026-07-19T23:44:46.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    New date entries were added to the study record's history and older date entries were removed, indicating maintenance of the record's update timeline rather than changes to the study data.
    Difference
    0.2%
    Check dated 2026-07-12T17:28:45.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site’s revision tag was updated from v3.6.2 to v3.6.3, indicating a maintenance release. The change does not alter the page content or the study details presented.
    Difference
    0.1%
    Check dated 2026-07-05T13:26:48.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The revision tag at the bottom was updated from v3.6.0 to v3.6.2, indicating a newer page build. Content and study data remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-28T06:39:15.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended. It also adds new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:01:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.